These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15450416)

  • 41. BRCA1 and TP53 mutation spectrum of breast carcinoma in an ethnic population of Kashmir, an emerging high-risk area.
    Eachkoti R; Hussain I; Afroze D; Aejazaziz S; Jan M; Shah ZA; Das BC; Siddiqi MA
    Cancer Lett; 2007 Apr; 248(2):308-20. PubMed ID: 16996204
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ESEfinder: A web resource to identify exonic splicing enhancers.
    Cartegni L; Wang J; Zhu Z; Zhang MQ; Krainer AR
    Nucleic Acids Res; 2003 Jul; 31(13):3568-71. PubMed ID: 12824367
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Accumulation of p53 protein in pterygia is not accompanied by TP53 gene mutation.
    Schneider BG; John-Aryankalayil M; Rowsey JJ; Dushku N; Reid TW
    Exp Eye Res; 2006 Jan; 82(1):91-8. PubMed ID: 16005868
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Distribution of SR protein exonic splicing enhancer motifs in human protein-coding genes.
    Wang J; Smith PJ; Krainer AR; Zhang MQ
    Nucleic Acids Res; 2005; 33(16):5053-62. PubMed ID: 16147989
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Why Selection Might Be Stronger When Populations Are Small: Intron Size and Density Predict within and between-Species Usage of Exonic Splice Associated cis-Motifs.
    Wu X; Hurst LD
    Mol Biol Evol; 2015 Jul; 32(7):1847-61. PubMed ID: 25771198
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mid-frequency DFNA8/12 hearing loss caused by a synonymous TECTA mutation that affects an exonic splice enhancer.
    Collin RW; de Heer AM; Oostrik J; Pauw RJ; Plantinga RF; Huygen PL; Admiraal R; de Brouwer AP; Strom TM; Cremers CW; Kremer H
    Eur J Hum Genet; 2008 Dec; 16(12):1430-6. PubMed ID: 18575463
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients.
    Alsner J; Jensen V; Kyndi M; Offersen BV; Vu P; Børresen-Dale AL; Overgaard J
    Acta Oncol; 2008; 47(4):600-7. PubMed ID: 18465328
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Missense mutations of
    Zhu M; Chen HM; Wang YP
    Oncol Lett; 2013 May; 5(5):1710-1718. PubMed ID: 23760103
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Genetic variations of the tumor suppressor TP53: outstanding and strategies of analysis].
    Rangel-López A; Piña-Sánchez P; Salcedo M
    Rev Invest Clin; 2006; 58(3):254-64. PubMed ID: 16958302
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Massive computational identification of somatic variants in exonic splicing enhancers using The Cancer Genome Atlas.
    Tanimoto K; Muramatsu T; Inazawa J
    Cancer Med; 2019 Dec; 8(17):7372-7384. PubMed ID: 31631560
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases.
    Blencowe BJ
    Trends Biochem Sci; 2000 Mar; 25(3):106-10. PubMed ID: 10694877
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structural assessment of single amino acid mutations: application to TP53 function.
    Yip YL; Zoete V; Scheib H; Michielin O
    Hum Mutat; 2006 Sep; 27(9):926-37. PubMed ID: 16917930
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluating the arrayed primer extension resequencing assay of TP53 tumor suppressor gene.
    Tõnisson N; Zernant J; Kurg A; Pavel H; Slavin G; Roomere H; Meiel A; Hainaut P; Metspalu A
    Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5503-8. PubMed ID: 11960007
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of functional exonic splicing enhancer motifs recognized by individual SR proteins.
    Liu HX; Zhang M; Krainer AR
    Genes Dev; 1998 Jul; 12(13):1998-2012. PubMed ID: 9649504
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A putative exonic splicing enhancer in exon 7 of the PDHA1 gene affects splicing of adjacent exons.
    Ridout CK; Keighley P; Krywawych S; Brown RM; Brown GK
    Hum Mutat; 2008 Mar; 29(3):451. PubMed ID: 18273899
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Functional analysis of splicing mutations in exon 7 of NF1 gene.
    Bottillo I; De Luca A; Schirinzi A; Guida V; Torrente I; Calvieri S; Gervasini C; Larizza L; Pizzuti A; Dallapiccola B
    BMC Med Genet; 2007 Feb; 8():4. PubMed ID: 17295913
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of splicing defects caused by mutations in the dysferlin gene.
    Kergourlay V; Raï G; Blandin G; Salgado D; Béroud C; Lévy N; Krahn M; Bartoli M
    Hum Mutat; 2014 Dec; 35(12):1532-41. PubMed ID: 25312915
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acetaldehyde-induced mutational pattern in the tumour suppressor gene TP53 analysed by use of a functional assay, the FASAY (functional analysis of separated alleles in yeast).
    Paget V; Lechevrel M; Sichel F
    Mutat Res; 2008 Mar; 652(1):12-9. PubMed ID: 18242117
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection of somatic TP53 splice site mutations in diffuse astrocytomas.
    Uno M; Oba-Shinjo SM; de Aguiar PH; Leite CC; Rosemberg S; Miura FK; Junior RM; Scaff M; Nagahashi Marie SK
    Cancer Lett; 2005 Jun; 224(2):321-7. PubMed ID: 15914282
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A general role for splicing enhancers in exon definition.
    Lam BJ; Hertel KJ
    RNA; 2002 Oct; 8(10):1233-41. PubMed ID: 12403462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.